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Iron is one of the trace elements playing a key role in the normal cellular metabolism. Since an excess of free iron is catalyzing the Fenton
reaction, most of the intracellular iron is sequestered in the iron storage protein ferritin. The binding of iron into ferritin is well described for
physiological conditions, however, under certain pathophysiological situations, the efficiency of this process is unknown. In the brain, microglial
cells are among others the cell population most importantly responsible for the maintenance of the extracellular environment. These cells might
undergo activation, and little is known about the expression of ferritin during activation of microglial cells. Therefore, we tested the microglial
model cell line RAW264.7 for the expression of ferritin after LPS activation. A significant decrease in the levels of the ferritin H-chain during
activation and a significant increase in the early recovery phase were found. We were able to demonstrate that reactive oxygen species are
responsible for a suppression of the H-chain of ferritin, whereas iNOS expression and NO synthesis are counteracting the reactive oxygen species
effect. The balance of reactive oxygen species and NO production are, therefore, determining expression levels of the ferritin H-chain during
activation of microglial cells.
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In the brain, the content of ferritin is high and can be strongly
altered during aging or in specific regions in brains of
Alzheimer's and Parkinson's patients [1–3]. Besides oligoden-
drocytes, microglia appears to have a high ferritin content, which
mostly consists of L-chains [4,5]. This is also a characteristic of
organs storing iron, like liver and spleen. Thus, microglia plays
an important role in brain iron homeostasis [6,7]. Another
characteristic feature of these cells is their ability to produce
reactive oxygen and nitrogen species upon activation [8–12].
Interestingly, the activation of microglia is accompanied by a
reversible oxidation of their own protein pool due to activation
[13,14]. This condition might be dangerous for the cell itself
and neighbouring neurons, since some oxidants, like superoxide
radicals, H2O2 and nitric oxide, are able to diffuse in biological⁎ Corresponding author. Fax: +49 211 3389 222.
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doi:10.1016/j.bbamcr.2006.04.012tissue for some distance. On the other hand, such oxidizing
species are altering the iron sequestering function of ferritin
[15,16] and furthermore trigger the release of iron directly from
ferritin in vitro [17–22].
Due to the fact that microglial activation produce vast
amounts of reactive oxygen and nitrogen species and in
consequence damage their own protein pool, it is important to
know how activation ofmicroglial cells is influencing the ferritin
content in these cells and which role oxidizing species are
playing in the modulation of ferritin expression. Therefore, we
utilized in this study mouse RAW264.7 cells as a known
microglial model and examined their ability to maintain a ferritin
steady-state concentration in response to LPS activation.
2. Materials and methods
2.1. Cell culture
RAW264.7 macrophages were cultured in RPMI medium supplemented
with 10% foetal bovine serum (Biochrom). Cells were plated at a density of
Fig. 1. Regulation of H-chain ferritin levels in RAW264.7 cells during
activation. Cells were cultivated and treated with the iron chelating agent
desferioxamine as described in the Materials and methods section. In panel A,
an immunoblot developed with an anti-ferritin antibody of cell lysate of
RAW264.7 cells with and without desferioxamine (Desf) incubation is shown.
Panel B demonstrates the quantitative evaluation of 3 independent experiments
with the control (−Desf) set as 1 (mean±S.D., *P<0.05). The effect of LPS
was tested after a 16-h incubation with LPS (LPS) and following 24 h of
recovery (LPS+24 h). Panel C demonstrates the quantitative evaluation of 4
independent experiments with the control (C) set as 1 (mean±S.D., *P<0.05).
The effect of the antioxidant PBN on the expression of H-chain of ferritin was
tested in non-activated and activated Raw264.7 cells. Panel D demonstrates the
quantitative evaluation of 3 independent experiments with the control (C) set
as 1 (mean±S.D., *P<0.05).
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scraped in medium and centrifuged for 8 min at 4 °C and 200×g followed by
two steps washing with PBS.
2.2. RAW cell stimulation and treatment with the different chemical
compounds
For the iron depletion experiment cells were incubated 16 h with 100 μM
Desferioxamine. RAW cells were activated by treatment with 10 μg/ml LPS for
16 h. Then either the cells were immediately harvested or further cultivated with
normal RPMI medium for the next 24 h. In the case of iNOS inhibition, the
potent inhibitors 1400 W hydrochloride (Calbiochem) and L-NIL (Calbiochem)
were added to the cells during LPS activation at 25 μM of each. To analyze the
effect of free radicals cells were additionally incubated with N-tert-butyl-α-
phenylnitrone (PBN, Sigma), a commonly used free-radical spin trap, at a
concentration of 600 μM.
2.3. Immunoblot analysis
Briefly, proteins were extracted from RAW cells by gentle shaking in lysis
buffer (1 mMDTT in 25 mM Tris pH 7.4 and 50 mMNaCl) 1 h on ice, followed
by centrifugation at 14,000×g (Beckman) for 30 min at 4 °C. The supernatant
was removed for protein determination by the BCA kit (Pierce). Identical
amounts of total protein were boiled in loading buffer before electrophoretic
separation (12% SDS-PAGE), transferred to a PVDF membrane, blocked with
5% skim milk in PBS/0.5% Tween 20, incubated with primary (anti-human-
ferritin, Dako) and secondary antibody (anti-rabbit-IgG HRP-conjugated,
Sigma), and finally analyzed for immunoreactivity using a POD chemilumi-
nescence kit (NEN). Pre-stained precision markers were used to estimate the
apparent molecular weight of the protein bands. The relative optical densities
were quantified using TabLab software.
2.4. Detection of nitrite/nitrate species (NOx)
From a stock nitrite standard (0.1 M sodium nitrite) a fresh 0.1 mM sodium
nitrite solution was prepared immediately followed by 6 serial 2-fold dilutions to
generate the nitrite standard reference curve. 50 μl of the nitrite standards and the
cell culture supernatants were pipette into a 96-well plate. Accordingly, 100 μl
Griess (Fluka) reagent was added and incubated for 10–15 min at room
temperature. The formed purple/magenta colour was detected by measuring the
absorption at 550 nm in a plate reader.
2.5. ELISA for detection of protein oxidation
The protein carbonyl content was taken as a measure for protein
oxidation. Protein carbonyls were determined in cell lysates (4 mg/ml in lysis
buffer with 1 mM BHT) by an ELISA as introduced by Buss et al. [23] with
modifications described by Sitte et al. [24]. Primary anti-dinitrophenyl–
rabbit–IgG antiserum (Sigma) and a secondary monoclonal anti-rabbit–POD-
conjugated IgG (Sigma) were used as detection system. Development was
performed with o-phenylene diamine and H2O2.
2.6. Statistical evaluation
Data are presented as mean±S.D. Significance of differences was tested
using the Student's test considering P<0.05 as significantly different.
3. Results
3.1. Reduction of Ferritin by iron depletion
Ferritin is the most important intracellular iron storage, and
the cellular ferritin level is regulated by the effective iron
concentration in the cell. To test whether the ferritin level in
RAW264.7 is regulated as usual, we compared the ferritin levelin RAW264.7 cells under normal conditions with conditions of
cellular iron depletion, simulated by adding 100 μM desferriox-
amine, known as iron chelator (Fig. 1A). The antibody is
recognizing only the H-chain of ferritin as reported before [16].
The ferritin H-chain level was strongly reduced after desfer-
rioxamine treatment approximately by 70% (Fig. 1B). This
proves the direct relationship between cellular free iron
concentration and cellular ferritin level.
3.2. LPS stimulated ferritin reduction and ferritin overload
during recovering in RAW264.7 cells
Our primary goal was the investigation of the ferritin level
during activation of RAW264.7 cells. Therefore, we stimulated
RAW cells using LPS. As shown in Fig. 1C, after 16-
h incubation with LPS, the level of the ferritin H-chain is
minimally, but significantly decreased by about 20%. However,
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of ferritin rebounded and achieved an approximately 40%
higher level as compared to the control level. Since we
demonstrated earlier that reactive oxygen species induce a
reduction of the ferritin level in RAW264.7 cells [16] and LPS,
as some other activators, is inducing an oxidative burst in
RAW264.7 cells [13,25] we assumed, the reduction of ferritin
might be triggered by oxidants produced during the activation
of RAW cells. The high level of ferritin following recovering
might display an adaptive response to oxidative stress, since it
has been shown that ferritin appears to be a protein with
antioxidative properties.
3.3. Co-incubation with the free radical scavenger PBN
prevents LPS stimulated ferritin reduction
To test the idea whether the presence of reactive oxygen
species might be responsible for the decreased ferritin level in
LPS-activated microglia, RAW264.7 cells were stimulated for
16 h with LPS in the presence of PBN, a well-known free
radical scavenger. As demonstrated in Fig. 1D, the co-treatment
LPS/PBN could prevent the LPS stimulated reduction of the
ferritin H-chain and resulted in a ferritin H-chain level higher as
compared to the untreated control. This is showing the
involvement of ROS in reducing the H-chain ferritin level in
LPS-activated macrophages/microglia. Interestingly, after a
24-h recovery phase of the RAW264.7 cells the H-chain ferritin
level was increased to about 400% in the presence of PBN. This
indicates an improved adaptive response of microglial cells
protected by PBN. On the other hand, PBN alone without any
stimulation did not affect the level of the H-chain of ferritin
(Fig. 1D).
To test whether the addition of PBN was really effective in
preventing protein modification in activated microglial cells, we
measured the protein carbonyl content as a marker of protein
modification. As demonstrated in Fig. 2, the amount of protein
carbonyls is extremely elevated to more then 250% in the LPS
stimulated RAW64.7 cells as compared to the untreated controlFig. 2. PBN modulates the protein oxidation in LPS-treated RAw264.7 cells.
Protein oxidation in RAW264.7 cells was determined 16 h after LPS or LPS and
PBN addition by measuring protein carbonyl levels as described in the Materials
and methods section. The data represent the mean±S.D. of 3 independent
experiments with 4 measurements each (*P<0.05).cells. Whereas addition of PBN during LPS activation revealed
a lesser formation of protein carbonyls, about a third lower than
in cells treated with LPS alone.
3.4. LPS stimulated ferritin reduction is boosted by
simultaneous iNOS inhibitor treatment
It is well known that reactive microglial cells activated by
LPS are releasing besides reactive oxygen species also reactive
nitrogen species. This is the consequence of the iNOS induction
and the production of the free radical nitric oxide (NO). NO has
been shown to bind to iron sulphur centres of enzymes, thus
interfering with the functioning of those enzymes such as
cytosolic aconitase also known as iron regulatory protein IRP1
[26,27]. On the other hand, NO has been proposed to act as a
factor preventing the effects of reactive oxygen species by a
very efficient reaction with the superoxide radical forming
peroxynitrite, a potent oxidant, but unable to diffuse larger
distances in biological tissues [28–31].
Therefore, we tested the role of reactive nitrogen species on
the ferritin production in activated RAW264.7 cells. To
investigate the influence of NO production on ferritin levels,
RAW cells were simultaneously incubated with specific iNOS
inhibitors 1400 W and L-NIL during their LPS activation. The
addition of iNOS inhibitors caused an additional ferritin
reduction around 20–25% (Fig. 3A). This would agree with
the fact that NO is reducing the reactive oxygen level, and
therefore, the inhibition of NO production is further reducing
the content of the ferritin H-chain due to enhanced ROS
action.
In order to be sure, that the LPS activation was successful in
our hands, NOx concentrations were determined by using Griess
reagent showing a strong production of NOx by LPS, almost
completely abolished by simultaneous addition of iNOS
inhibitors (Fig. 3B).
4. Discussion
On one hand, ROS production is a natural result of the
oxidative metabolism in mammalian cells connected with
oxidation of proteins and consequently with increased intracel-
lular proteolysis [16,32]. On the other hand, this basal ROS
production is boosted by activated microglia/macrophages as
defence mechanism against several pathogens. Iron plays a
critical role during this process due to its catalyzing effect on the
generation of free radicals by hydrogen peroxide via Fenton
reaction. Under physiological conditions, excess intracellular
iron is sequestered in ferritin, in order to prevent this process.
Ferritin levels are modulated by cellular iron content [33–36].
We were able to demonstrate also the modulation of ferritin H-
chain expression by free iron in RAW264.7 cells (Fig. 1).
However, the ferritin content is decreased in presence of
reactive oxygen species, due to the oxidation of intracellular
ferritin and consequent proteasomal degradation and a reduced
ferritin synthesis [16]. Such an oxidative stress-mediated effect
on the ferritin H-chain was confirmed by our results
demonstrated here with LPS-activated RAW cells showing a
Fig. 3. iNOS inhibition facilitates LPS-mediated effects on ferritin levels. Ferritin expression was measured either without addition, 16 h after LPS addition or the
addition of LPS and iNOS inhibitors. As iNOS inhibitors 1400Wand L-NIL were used in parallel. Panel A shows the quantitative evaluation of the ferritin expression
determined by immunoblots (mean±S.D., n=4, *P<0.05). Panel B shows the formation of NOx after treatment with LPS, or LPS and iNOS inhibitors (mean±S.D.,
n=5, *P<0.05).
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is inhibitable by PBN treatment.
Previous work of us [24,37–40] and others [41–43]
demonstrated the role of the proteasomal system in the removal
of oxidized proteins from the intracellular protein pool. A self-
oxidation of intracellular proteins during microglial activation
and the efficiency of the proteasome in the restitution of the
intracellular protein pool were already demonstrated [13,16,32].
These results could be confirmed by measurements of increased
protein carbonyl formation due to activation of RAW264.7 cells
and the partial reduction by the usage of PBN (Fig. 2).
LPS-mediated activation of microglial cells is going along
with the production of multiple factors and reactive species.
One of most potent changes during microglial activation is the
high elevated NO production caused by induction of iNOS [44–
48]. LPS stimulation also causes high fluxes of superoxide
radical induced by NADPH oxidase activation [25]. Under such
conditions, Mn-superoxide dismutase is induced in microglial
cells [49]. However, the produced NO is giving a number of
chemical reactions, one of the most important is the reaction
with the superoxide anion radical and the formation of
peroxynitrite [28–31]. This reaction is taking place at a nearly
diffusion limited rate and was already several-fold demonstrated
to take place in activated macrophages and microglia [28,50].
At least these four reactive oxygen species: superoxide anion
radical, NO, ONOO− and H2O2 influence directly or indirectly
the ferritin level and the binding activity of iron regulatory
proteins (IRPs) [15,16,26,27,51–57]. Besides the protein
synthesis modulated by the IRPs, the ferritin level is of course
also regulated by the proteolysis rate.
As does iron chelation by desferal, endogenous NO
production abolishes completely aconitase activity by disas-
sembling the [Fe-S] cluster and strongly activates IRE binding
by IRP1 resulting in inhibited ferritin synthesis over a long time
period [26,27,51]. In contrast, under reducing conditions, the
full IRP1/IRE-binding capacity is 50% reduced, caused by a
50% decrease in IRP1 protein level [52]. A reduction is also
caused by ONOO−-mediated IRP1 tyrosin nitration in responseto endogenous NO synthesis [51]. However, also H2O2
[15,16,26,27,53,54] and superoxide anion radical [55–57]
inactivate the c-aconitases and support induction of IRP/IRE
binding and inhibition of ferritin synthesis, which appears to be
a fast response (maximal IRP1 activation between 30 and
60 min) [26,27,53]. Therefore, we speculate that the main part
of ferritin reduction in LPS stimulated RAW cells is due to
inhibition of ferritin synthesis via increased IRP1/IRE binding
induced by ROS, since PBN prevents this effect.
It has been demonstrated in vitro that different oxidants as
superoxide radical, NO, ONOO− and H2O2 increases the
proteolytical susceptibility of ferritin [21]. These data were
confirmed in H2O2 treated RAW macrophages, where signif-
icant increased ferritin degradation was observed [16]. Addi-
tionally, it has to be mentioned that in vitro different oxidants, as
for example superoxide radical and H2O2, are able to release
iron from ferritin, which can catalyze the decomposition of
hydroperoxides resulting in new toxic radicals [18,21,22]. Thus,
ferritin can be oxidatively damaged and in consequence is
degraded by proteasome [16,21]. Therefore, LPS induced ROS
production in macrophages might accelerate ferritin proteolysis.
At this point, it should be mentioned that at moderate H2O2
concentration H-ferritin seems to be faster degraded as
compared to L-ferritin, despite its less susceptibility for
oxidation [16], possibly in order to prevent additional hydrogen
peroxide production by the H-ferritin-mediated ferroxidase
activity [58–60]. The above discussed facts concerning
inhibited ferritin synthesis and accelerate ferritin proteolysis
are explanations for the observed decreased protein level of
ferritin after LPS stimulation in macrophages and the preventing
effect by PBN.
Interestingly, NO seems to have a protecting effect on
ferritin, since inhibition of NO formation by adding iNOS
inhibitors reveals a much stronger ferritin reduction in LPS
stimulated RAW cells. Although the result of the NO reaction
with superoxide is the very potent oxidant peroxynitrite, it
seems to be likely that the enhanced formation of NO might
reduce the oxidative damage to cells [61–63]. This is likely due
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biological tissue and the prevention of ROS-mediated effects
and signalling in dependency of SOD activity [31]. Otherwise,
RNS are suggested to work as scavenger for peroxide radicals
produced through the Fenton reaction. Under LPS stimulation
reactive nitrogen species (RNS) appear to have an ROS effect
eliminating function [64]. In our model, the inhibition of iNOS
is enhancing the ROS-mediated depletion of ferritin, indicating
a protective role of the produced NO on the ferritin pool.
Taken together, all these data indicate that intracellular
ferritin level is strongly regulated by complex interaction
between iron load, cytokine release (for example TNF-α) and
NO and superoxide radical production in activated microglial
cells. Such findings implicate that the iron-dependent free
radical production may represent another useful defence
system, where NO has a major role in regulation of its strength.
Whether the ROS are directly affecting on the ferritin
molecule or the mobile iron pool, or the IRP1 and IRP2
molecules remains to be investigated in microglial cells.
However, independent on the mechanism the results presented
in this study identify a reduction of the most important cellular
iron-binding protein ferritin in consequence of ROS production
in LPS-activated RAW macrophages.
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